‘Time to Ground the Plane’: FDA Advisers Recommend JN.1 COVID Vaccines Despite Growing Evidence of Cancer Risks ‘Time to Ground the Plane’: FDA Advisers Recommend JN.1 COVID Vaccines Despite Growing Evidence of Cancer Risks June 6, 2024 In a unanimous 16-0 vote, the U.S. Food and Drug Administration’s vaccine advisory committee today recommended a monovalent JN.1-lineage for the 2024-2025 COVID-19 vaccine formula.…